Safety and Tumoricidal Effect of Low Dose Temoporfin Photodynamic Therapy in Patients With Inoperable Bile Duct Cancers (Foscan® Study)

Next Previous
Trial Profile

Safety and Tumoricidal Effect of Low Dose Temoporfin Photodynamic Therapy in Patients With Inoperable Bile Duct Cancers (Foscan® Study)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Apr 2017

At a glance

  • Drugs Temoporfin (Primary)
  • Indications Adenocarcinoma; Cholangiocarcinoma
  • Focus Adverse reactions

    • Most Recent Events

    • 20 Apr 2017 Planned End Date changed from 1 Aug 2017 to 1 Aug 2019.
    • 20 Apr 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2019.
    • 29 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top